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Trichloroethylene is an organic chemical that has been used in dry cleaning, for metal degreasing,
and as a solvent for oils and resins. It has been shown to cause liver and kidney cancer in
experimental animals. This article reviews over 80 published papers and letters on the cancer
epidemiology of people exposed to trichloroethylene. Evidence of excess cancer incidence among
occupational cohorts with the most rigorous exposure assessment is found for kidney cancer
(relative risk lRR] = 1.7, 95% confidence interval [Cl] 1.1-2.7), liver cancer (RR = 1.9, 95% Cl
1.0-3.4), and non-Hodgkin's lymphoma (RR = 1.5, 95% Cl 0.9-2.3) as well as for cervical cancer,
Hodgkin's disease, and multiple myeloma. However, since few studies isolate trichloroethylene
exposure, results are likely confounded by exposure to other solvents and other risk factors.
Although we believe that solvent exposure causes cancer in humans and that trichloroethylene
likely is one of the active agents, we recommend further study to better specify the specific agents
that confer this risk and to estimate the magnitude of that risk. Key words: cancer, degreasers, dry
cleaning, epidemiology, PERC, solvents, TCE, TCOH, tetrachloroethylene, trichloroethylene.
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Introduction
This article is a review ofthe epidemiologic
evidence regarding the possible carcinogenicity
oftrichloroethylene (TCE). Thebasicapproach
adopted uses as guidance Hill's (1) framework
for assessing causality and is based on the sub-
stantial epidemiologicliterature reportingpossi-
ble exposure to TCE. This literature ofover 80
published artides on TCE's carcinogenicity to
humans includes more than 20 reports on
worker cohorts, more than 40 case-control
studies, more than a dozen community-based
studies, and several commentaries and reviews.
We begin with a briefconsideration ofthe
experimental (animal) evidence for context.
Then we review the epidemiologic evidence,
beginning with the cohort studies in which
temporality is inherent, assessing strength, con-
sistency, and exposure response (biologic gradi-
ent). We consider the case-control studies to
determine ifthey provide supporting evidence.
Then we consider the community-based
studies, which have less accurate, less precise,
andlessspecific exposure information. We con-
dude with a discussion ofall ofthese data and
theprevious reviews andcommentaries.
One ofthe biggest challenges in interpret-
ing the studies involving exposure to TCE is
that exposure rarely occurs in isolation. That
is, most workers exposed to TCE also are
exposed to other solvents. This compromises
our ability to make solvent-specific response
evaluations. While we attempt to focus on
TCE-specific effects, we are limited by the
quality and specificity of the exposure data
developed for the studies reported.
Evidence fromAnimal Studies
Trichloroethylene is an organic chemical that
has been used for dry cleaning, for metal
degreasing, and as a solvent for oils and resins.
Because ofwidespread occupational expo-
sures, scientists have investigated its carcino-
genicity in animal models. It has been found
to be carcinogenic in both mice and rats,
which suggests that it may also be carcino-
genic to humans. A 1975 National Cancer
Institute (NCI) cancer bioassay report shows
increased liver cancer in both male and female
mice that had been administered TCE bygav-
age (gastric intubation) (2). Although the
TCE used in the NCI study was technical
grade (containing a small amount ofepoxybu-
tane and epichlorohydrin), a later replication
ofthis experiment using a pure solution of
TCE has similar findings. Additional bioassays
show evidence ofmalignant tumors of the
liver in mice byeither respiratory (3,4) or oral
exposure (5), although rats treated in a similar
mannershowcancer rates comparable to those
ofuntreated controls (6). The occurrence of
these liver tumors in mice is limited to
B6C3F, and Swiss strains; a number of
studies in other strains do not show elevated
incidences in liver tumors in treated versus
control animals. There is some beliefthat the
B6C3F, mouse is particularly prone to liver
tumors, suggesting that it may be a particu-
larly sensitive test animal. Besides liver
tumors, lung tumors (3,4,7), and lymphomas
(5) are found in mice inhalation studies.
Male and female rats exposed to TCE
both orally by gavage and via inhalation
develop renal tubular adenocarcinomas at low
incidences (3,4). These tumors are very rare
among rats, and their occurrence in the TCE
bioassays is considered biologically signifi-
cant, even though the increased incidences
are not statistically significantly elevated
above those ofcontrols. Additionally, Leydig
cell tumors of the testes (3,8) (inhalation)
andleukemia (4) in rats are observed.
Methods
Identification ofRelevantStudies
To conduct this review ofthe epidemiologic
evidence on the carcinogenicity ofTCE expo-
sures, we identified epidemiologic studies of
populations with known, suspected, and pos-
sible TCE exposure. Starting with the most
recent reviews, we followed backthe literature
and obtained more than 80 published articles
or letters, and several unpublished reports.
This was followed by a MEDLINE search
(9), which turned up a few additional articles.
The majority ofstudies available are occupa-
tional studies. There are 28 cohort studies (of
20 cohorts) that summarize outcomes in
groups ofexposed workers compared to those
not exposed (often the general population),
43 case-control studies (mainly at 15
anatomical sites) in most ofwhich the occu-
pational or exposure history ofworkers with
a particular cancer compared to that ofoth-
ers without that specific cancer (sometimes
workers, sometimes the general population),
15 reports of community-based studies of
disease rates in communities with contami-
natedwater supplies, and 3 case series reports
on cases without a comparison population.
Note that the term cohort refers to groups of
individuals followed from a disease-free state
regardless ofthe measure ofeffect used (stan-
dardized incidence ratio [SIR]; standardized
mortality ratio [SMR]; standardized mortal-
ity odds ratio [SMOR]; proportionate
mortality ratio [PMR]).
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Three ofthe cohort studies we identified
allegedly resulted from apparent clusters of
disease (10-12). An argument can be made
that studies initiated by a cluster report, even
though the studies are traditional and rigor-
ous cohort designs, should be excluded from
summaries such as this simply because it was
the observation of an apparent cluster that
generated the interest. Implicit in those
investigators' arguments is the assumption
that inclusion of these cohorts somehow
biases the overall assessment. We disagree,
provided the study is awell-conducted study.
We include all studies that we have been able
to identify in which the population had doc-
umented or even plausible exposure to TCE
regardless ofwhy the study was undertaken.
We did not include cluster studies per se but
only the cohort studies that ensued. By
examining all published cohort studies in
conjunction with the case-control- and com-
munity-based studies, we believe we can pro-
vide useful insight into the possible
association between TCE exposure and the
site-specific risk ofcancer.
ExposureAssessment
To study TCE as a cause of cancer, it is
necessary to document that the people more
likely to have disease are also the people
more likely to have been exposed to TCE
and ideally more highly exposed to TCE. In
a few of the studies, exposures are deter-
mined quantitatively from chemical mea-
sures of the TCE metabolite trichloroacetic
acid (TCA) in the workers' urine (U-TCA),
which is considered a biomarker. This pro-
vides a quantitative measure of exposure
that, in many ways, is preferable to qualita-
tive or descriptive exposure metrics. One
limitation of this approach is that it is a
short-term measure reflective of exposures
received over the past day and does not cap-
ture the long-term nature of exposure
including variation in an individual's job
history. In addition, variation caused by
sampling frame and changes in industrial
process are not accounted for in short-term
biomarker studies and may lead to misclas-
sification. Further, this biomarker does not
provide information about possible expo-
sure to other risk factors including other
solvents that may confound the association
under study.
For example, TCA is also a metabolite of
tetrachloroethylene (PERC), another com-
monly used solvent in the workplace. Urine
samples for which TCA is measured are not
specific to TCE when exposure to TCE and
PERC occur jointly, which can lead to mis-
classification. Only one study addressed this
limitiation by using separate biologic meas-
ures, one each to estimate TCE, PERC, and
1,1,1-trichloroethane exposures.
More generally, even though U-TCA can
quantify TCE exposure, it does not quantify
total solvent exposures. If one sees an
exposure-response gradient with TCE expo-
sure, that would provide supporting evidence
ofa causal association. However, ifexposure
to another solvent is correlated with TCE
exposure, it is not possible to completely sep-
arate theireffects (i.e., there can be confound-
ing). In short, without comprehensive
exposure information, one's ability to make
robust inferences aboutTCE is more limited.
In studies not using biomarkers,
researchers often infer exposure by using an
individual's employment history, sometimes
combining the title ofeach job held by the
worker with the length of employment in
that job. Data for each job can be summa-
rized in quantitative measures such as the
number ofyears worked in a particular job
and the specific period ofyears worked. If
job title information is limited to a single
job (e.g., dry cleaners), exposure may be
summarized as a binary variable (exposed or
not exposed). If a variety ofjob titles are
reported (e.g., several different jobs all
involving degreasing, such as in aircraft
maintenance), then a categorical quantitative
measure ofjob-specific exposure may be
developed, such as one contrasting low,
medium, and high exposures for different
job titles. These categories can be derived
using information from a variety of sources
including interviews with long-time work-
ers, walkthroughs by trained industrial
hygienists, and more rarely, monitoring
data. When such a classification is combined
with an individual's job history information,
it is called a job exposure matrix (JEM).
Most often, exposure to TCE is inferred
from ancillary information, such as job title
and industrial process, rather than direct
monitoring or measurement of biomarkers
or air measurements. 'While this captures the
time history of exposure, it may result in
misclassification of exposure because the
actual exposures typically varied markedly
among workers with the same job title and
varied over time among those with the same
job title; some study subjects may have had
little to no exposure to any TCE, while oth-
ers may have had substantial exposure. In
summary, job history information can be
used to develop very simplistic measures of
exposure with much misclassification (e.g.,
some or no exposure; routine, intermittent,
or frequent exposure) to more sophisticated
measures that rank jobs and exposures on a
continuous, quantitative scale. Few studies
address the joint distribution ofTCE with
other solvents.
Studies ofdry deaner and laundryworkers
are included in this review, since these workers
may have been exposed occupationally to
TCE. TCE was commonly used in dry
cleaning from 1930 until 1960, along with
petroleum-based solvents such as Stoddard's
solvent. From the mid-1950s on, a change in
dry cleaning technology resulted in the
substitution of PERC for TCE and some
petroleum solvents. PERC is classified by the
International Agency for Research on Cancer
(IARC) as aprobable human carcinogen (13).
In the dry cleaning industry, TCE exposure
was mainly pre-1960, and it was followed by
exposure to PERC for general dry cleaning
after the 1960s. Exposure to petroleum-based
solvents and TCE for spot removal occurred
throughout the time period (13,14).
However, even when TCE was available for
dry cleaning, its use was limited because it
caused dyes (i.e., colors) to run. Petroleum
solvents were generally preferred (14). Since
TCE was used in the dry cleaning industry,
studies assessing dry cleaning exposure are
included in this review provided that they
include workers exposed before 1960. None
ofthe dry cleaner and laundry worker studies
reviewed separates TCE exposures from other
solvent exposures [except one study that pro-
vides data on both the entire cohort and a
TCE-only exposed cohort (15)], once again
raising questions aboutspecificityofexposure.
We divide the cohort studies into three
tiers based on the specificity ofthe exposure
information. Tier I studies are those in which
TCE exposure has been inferred for individ-
ual studysubjects and in which it is best char-
acterized. This includes studies that used
biomarkers and JEMs, and studies that con-
ducted other worksite exposure evaluations
such as walkthroughs. Tier II studies are
those in which there is putative TCE expo-
sure, but individuals are not identified as
uniquely exposed to TCE. Tier III studies are
thestudies ofdrycleanerand laundryworkers
in which subjects are exposed to a variety of
solvents including TCE. There are 11 Tier I
studies describing seven cohorts, 8 Tier II
studies describing seven cohorts, and 9 Tier
III studies describing six cohorts.
Characteristics ofthese studies are shown in
Tables 1-3.
Case-control studies mainly use job titles
to describe exposures. We do not subdivide
these. Community-based studies are far fewer
in number and use a variety of methods to
describe exposures. Again, these are not
subdivided.
StudySummaryMethods
Given the large number ofstudies to assess,
we use an ad hoc system to summarize the
data. First, we consider cohort studies as most
reliable design of the studies reviewed. To
avoid undue heterogeneity among the tiers,
we summarize the studies separately for each
tier, providing an estimate ofthe average risk
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across studies. Then, we consider the
case-control studies, which we evaluate for all
anatomical sites reported in the cohort
studies. Exposure characterization varies
widely among studies, usually reflecting job
title. Rather than summarizing disparate
exposures in a single average risk summary, a
descriptive summary of the studies is pre-
sented for the cancer sites, with the most
compelling results in the cohort studies. The
community-based studies represent the set of
studies in which TCE is identified as a possi-
ble or likely contaminant in the drinking
water. Again, since exposures (and exposure
characterizations) vary widely, as do out-
comes reported, we present a summary result
for each study rather than averaging them
together.
Average risk calculation. To summarize
the results ofcohort studies within the same
tier, we calculate an average relative risk using
a meta-analysis-type approach. To do so, we
calculate a weighted average ofthe individual
measures ofeffect (i.e., SMRs, SMORs, SIRs,
or PMRs), where the weights are the inverse
ofthe variance of the individual measures
(16). For those studies not reporting the vari-
ance, we calculated it using the formulas pre-
sented by Rothman and Boice (17). In
situations where the reported confidence
interval was not symmetric about the
reported odds ratio (on a log scale), we recal-
culate the individual lower confidence limit
based on the reported upper confidence limit,
for consistency in the average.
Results
CohortStudies
Tier I cohort studies. This set of studies
(Table 1) determines exposures using urinary
biomarkers (18), job exposure matrices
(19-23), and job histories (10,24). The
studies using urinary biomarkers represent the
most direct assessment of exposure, although
we have no way to gauge their accuracy. In
one cohort, Axelson et al. (18,25) examine
the incidence and mortality experience of
Swedish TCE production workers. Workers
themselves were able to request urine tests
from a program designed to determine their
TCE exposure using U-TCA only. The
authors emphasize that exposures tend to be
relatively low, with over 80% of the cases
exposed to an average ofless than 20 ppm. In
the other biomarker study (24,26) ofFinnish
workers with known TCE exposure as identi-
fied through records ofthe Finnish Institute
ofOccupational Health (Helsinki, Finland),
three different biomarkers are were used: uri-
nary TCA (for the period 1965-1982), blood
perchloroethylene (1974-1983), and blood
1,1,1-trichloroethane (1974-1983). Using
these three measures, researchers were able to
distinguish among exposures to TCE, PERC,
and 1,1,1-trichloroethane, which often are
intermingled in other studies. Again, expo-
sures are relatively low, with over 90% ofthe
exposures below40 ppm.
The studies using JEMs to determine
exposure employed various combinations of
industrial hygiene evaluations, walkthroughs,
interviews with employees, and monitoring
data combined with work histories. Some
characterize exposures by intensity, fre-
quency, and duration, while others use overall
assessments. Generally, three or more cate-
gories ofexposure are used for each type of
assessment. Again, thesestudies are limited by
the absence ofinformation on thejoint distri-
bution of the variety solvents (and other
agents) in each workplace. Three ofthese are
studies ofaerospaceworkers, one is a study of
cardboard manufacturers, and one is ofura-
nium processers. The aerospace and card-
board workers use TCE for degreasing,
whereas the uranium processers use it for
chemical processing.
Overall, these are high-quality studies.
They have moderately long follow-up periods
(17-38 years) but do not adjust for many
confounders. In general, the total mortality
and cancer mortality SMRs are close to 1.0.
No table deviations are seen for total mortal-
ity in Henschler et al. (10), Boice et al. (21),
and Ritz (23) and for cancer mortality in
Axelson et al. (18), all exhibiting a moderate
healthy-workereffect.
Tier II cohort studies. Several studies
(Table 2) evaluate the mortality experience of
workers using job titles and other general
information to assess potential exposure to
TCE and other chemicals. These include
studies ofthe U.S. Coast Guard inspectors
(27), workers in the metal polishing and plat-
ing industry (28), jewelry workers (29),
Table 1. Tier l: a summary of cohortstudycharacteristics.
Exposed
Follow-up, % Ascer- workers, Total Total cancer Total cancer
Reference Exposure assessment Outcome years tainment no. mortality mortality incidence Exposure-response data
Anttila etal. (24) Urinary biomarkers: U-TCA, I, SIR 26 100 3,089 0.9(0.8,1.0) 1.0(0.8,1.2) 1.1 (0.9-1.2) Years since measured;
Tola et al. (25) B-Per, B-TC U-TCA (each site)
Axelson etal. Urinary biomarker: U-TCA I, SIR 32 100 1,727 1.0(0.9-1.1) 0.7 (0.5-0.9) 1.0(0.8-1.2) Exposuretime; U-TCA(liver,
(18,25) prostate, skin)
Spirtas etal. (19) Occupation: aircraft main- I, RR 17 7,204 1.0(1.0-1.1) 1.1 (1.0-1.3) 1.2(1.0-1.6) Cumulative unit-years
Blair et al. (20) tenance; JEM (IH walk D, SMR 17 (eachsite)
throughs, interviews,
monitoring)
Boice etal. (21) Occupation: aircraft manu- D, SMR 36 2,267 0.8(0.8-0.9) 0.9(0.8-1.0) - Number ofyearsexposed
facturing; JEM (IH files,
walkthroughs, interviews)
Henschler etal. Occupation: cardboard D, SMR 34 97 259 0.7 (0.5-0.9) 1.0(0.5-1.7) Exposed vs unexposed
(10) workers; walkthroughs,
interviews, and company
use records (all exposed)
Morgan et al. Occupation: aerospace D, SMR 36 96 4,733 0.9(0.8-1.0) 0.9(0.8-1.0) - Cumulative exposure(high
(22) (degreaser); JEM (worker vs low; all sites); peak
Wong and Morgan interviews only) high vs low(liver, kidney,
(104) bladder, prostate, ovarian)
Ritz (23) Occupation: nuclearworker D, SMR 38 2,971 0.8(0.8-0.9) 1.1(1.0-1.2) - Number ofyearsexposed
(uranium); JEM (worker
interviews only)
Abbreviations: B-Per, perchloroethylene in the blood; B-TC, 1,1,1-trichloroethane in the blood; D, mortality (death); 1, incidence; IH, industrial hygiene assessment; JEM, job exposure matrix; O/E,
observed/expected.
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workers in aircraft manufacturing (30),
workers in lamp manufacturing (11), workers
at a plant using TCE as a degreasing agent
(31), and workers in paperboard printing
(12,32). These studies are very heterogeneous
and fewhave anyexposure data.
Implicit in the analysis of these data is
the assumption that all members of the
cohort have greater exposure to TCE than
the comparison population; however, much
uncertainty attends this assumption.
Exposures among individuals with the same
job title likely vary considerably. Patterns of
disease may be suggestive but cannot be con-
clusive in light of the possible unadjusted
confounding and lack of individual TCE
exposure estimates. Overall, total mortality
and total cancer mortality SMRs are near
1.0, suggesting aweak or nonexistent healthy
worker effect.
In the study ofCoast Guard inspectors,
exposure to chemicals including organic sol-
vents is categorized into three classes by
reviewing job duties, recognizing that various
solvents were used on the job (27). Several of
the other studies characterize exposures by
job title only, even though exposures were far
more complex. For example, metal polishing
and plating workers are exposed to heavy
metals, acids, alkaline solutions, and solvents
(28), jewelry workers are exposed to heavy
metals and solvents (29), and aircraft manu-
facturing workers are exposed to metals, oils,
paints, solvents, and other chemicals (includ-
ing an estimate based on a case-control study
of70 subjects in which 37% ofthe jobs had
TCE exposure (30). In all ofthese studies, all
workers are considered exposed and com-
pared to a putatively unexposed reference
population. In several ofthe studies, expo-
sure-response analyses were conducted using
years of exposure as a proxy. The study of
lamp manufacturing included review of
reported amounts of chemicals used in the
facility including methylene chloride and
TCE (11).
The final study in this tier reported on
paperboard printing in which TCE was used
in the finishing department. Exposure can be
inferred from the identification ofa materials
safety data sheet (MSDS) listing TCE as a
possible chemical exposure, and from a letter
from a National Institute ofOccupational
Safety and Health (Cincinnati, OH) investi-
gation, in which the specific TCE-containing
product is identified for use in the finishing
department (33).
One study is not included in the analyses
because mortality outcomes are only broadly
grouped, e.g., respiratory system, and not
presented for specific sites such as the kidney
or liver (31).
Tier III cohort studies. Several studies
(Table 3) of cancer mortality among dry
cleaner and laundry workers have been con-
ducted (15,34-41). Exposures are assessed
through job title only. As noted above, the
solvents used in dry cleaning changed over
time. TCE was mainly used prior to 1960,
after which it was replaced by PERC.
Thereafter, its use was primarily for spot
removal, but dry cleaners often preferred
Stoddard's solvent. The studies included in
this tier all report on workers initially
employed prior to 1960 to ensure that there
Table 2. Tier Il: summary ofcohort studycharacteristics.
Follow-up, % Ascer- Workers,
Reference Exposure assessment Outcome years tainment no. Total mortality Total cancer Exposure-response data
Blair et al. (27) U.S. Coast Guard inspectors; chemical D, SMR 38 - 1,292 0.8(0.7-0.9) 0.9(0.7-1.1) Cumulative exposure
exposures on inspection of cargo tanks
and othershipboard locations
Blair etal. (28) Occupation: metal polishing, plating; D, PMR 19 85 1,767 1.0(0.9-1.1) 1.1 (1.0-1.2)
possible exposure to solvents
Dubrowand Occupation asjewelryworker; possible D, PMR 11 _ 3,141 - 1.0(0.9-1.1) f
Gute (29) exposure to solvents 1.0(0.9-1.1) m
Garabrant et al. Occupation: aircraftworker; exposure D, SMR 25 95 14,067 0.8 (0.7-0.8) 0.8 (0.8-0.9) Duration of employment
(30) based on 70 subjects in a case control (esophagus, pancreas,
study; only37% jobs had TCE exposure bladder)
Shannon et al. Occupation: lamp manufacturing; TCE I, SIR 23 90 1,870 - 0.9(0.6-1.2) m Years exposed (breast and
(11) listed on engineering instruction sheet 1.1 (0.8-1.3)f gynecological together)
Shindell and Occupation: brake manufacturing D, observed 26.5 98 - 0.8(0.6-0.9) 0.7 (0.1-1.0)
Ulrich (31) vs exposed
Sinks etal. Occupation: paperboard workers; MSDS I, SIR 53 99 2,086 1.0(0.9-1.2) 0.6(0.3-0.9)
(12,32) listsTCE containing product for use in D, SMR
finishing department
Abbreviations: f, females; m, males.
Table3. Tier Ill: dry cleaners and laundryworkers-summary of cohort studycharacteristics.
Follow-up, % Ascer- Workers,
Reference Outcome years tainment no. Total mortality Total cancer Exposure years Exposure-response data (site)
Blair et al. (34,39) D, PMR 30 - 1.0(0.9-1.1) 1.3(1.1-1.5) 1948-1979 low, medium, high (esophagus, cervix,
D, SMR 32 0.9 (0.9-1.0) 1.2(0.4-1.1) 1949-1979 bladder, lymph/hematopoietic)
Duh and Asal (36) D, SMOR - - 5,365 1.0 (0.9-1.1) 0.9(0.7-1.2) < 1980
Katz and Jowett D, PMR - - - 1.0 (0.8-1.1) < 1977
(35)
Lynge and Thygesen(40) I, O/E 10 - 10,600 - 1.3 (1.1-1.4) m
1.0 (0.9-1.1) f 1946-1970
Lynge (41)
McLaughlin etal. I, SIR - - -
(38)
Ruder(15) D, SMR > 31 93 1.0 (0.9-1.1) m 1.2 (1.0-1.5) m 1940-1990 Latency, length of employment
Brown and Kaplan (37) 1.1 (1.0-1.2) f 1.3 (1.0-1.5) f (intestine, bladder)
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was an opportunity for exposure to TCE.
Laundry workers are often included in dry
cleaner cohorts even though they likely do
not have any TCE or PERC exposure;
this results in further misclassification
(35,36,40,41). Only the studies ofRuder et
al. (15), Brown and Kaplan (37), and Blair
et al. (39) limited their study populations to
dry cleaners.
Overall, total mortality rates generally are
close to 1.0 but slightly elevated more often
than not. Some total cancer mortality rates
exceed 1.0, suggesting excess risk ofcancer
overall. Unfortunately, for the specific-site
analyses, many different effect measures are
used (i.e., PMR, SMR, SMOR, SIR), making
quantitative comparisons difficult to inter-
pret. These cohort studies are the least spe-
cific to TCE exposure.
Exposure-response evaluation. The iden-
tification ofexposure-response gradients, or
trends, provides particularly compelling evi-
dence supporting a hypothesis ofcausation.
Studies using U-TCA as a biomarker for
TCE exposure provide data stratified by spe-
cific exposure levels that are amenable to
trend analysis. Other studies provide infor-
mation about the number ofyears worked or
cumulative exposure (from a job exposure
matrix), which can be used for indirect
exposure-response analysis. Both Anttila et
al. (24) and Axelson et al. (18) report SIR
results stratified by level ofexposure (above
or below 100 jmol/L U-TCA) and duration
[years since first measurement in Anttila et
al. (24) and exposure time in Axelson et al.
(18)]. Blair (20) provides TCE exposure-
response data for mortality and incidence
compared to those with no chemical expo-
sure, stratifying results jointly by gender and
four levels of TCE exposure (none, < 5
units/year, 5-25 units/year, > 25 units/year).
The relative exposure scores are based on the
exposure intensity, frequency, and duration
ofpeak exposures from vapor degreasing and
on low-level exposures at the workbench and
surveys during the 1960s and 1970s ofwork
practices at degreasers. Morgan (22) reports
mortality results for dichotomous exposure
categories separately for peak and cumulative
exposure metrics based on analyses with the
Cox proportional hazards model. Ritz (23)
presents data cross-classified by two levels of
exposure, two lag periods (0 and 15 years),
and two periods ofexposure duration (> 2
years, > 5 years). Boice (21) reports data for
TCE-exposed workers stratified by years
exposed. Specific patterns of exposure
response will be discussed below.
Case-Control Studies
Several case-control studies were conducted
for situations of likely TCE exposure.
These include studies of bladder cancer
(12,42-45), brain cancer (46,47), buccal
and oral cancers (48,49), childhood brain
cancer (47), childhood leukemia (50), child-
hood cancers (51), colon cancer (52),
esophageal cancer (49,53), Hodgkin's disease
(54-56), kidney cancer (12,57-68), laryn-
geal cancer (49), leukemia (50), liver cancer
(59,69-75) lung cancer (76), melanoma
(77), non-Hodgkin's lymphoma (54,55,
78-80), and pancreatic cancer (81,82). Most
kidney cancer studies examine renal cell car-
cinoma, although a few also assess cancer of
the renal pelvis. We group these studies
together as reporting kidney cancer.
Two investigators each report a series of
nested case-control analyses conducted
within their own cohort. In one, Greenland
et al. (83), studying a cohort oftransformer
assembly workers, evaluates the risks to white
males from specific exposure (e.g., pyranol,
benzene, TCE, solvents, machining fluids,
asbestos, resin systems). In the other,
Siemiatycki reports on a study of3,730 men
35-70 years ofage in Montreal, Canada, dur-
ing 1979-1985 with cancer at 21 anatomical
sites and 533 population controls ofsimilar
ages (84). Subjects were interviewed about
their occupations, and exposures to 293
agents or mixtures were estimated by a group
of chemists. The estimated prevalence of
TCE exposure was 2%.
In general, the case-control studies do not
provide the same specificity for TCE expo-
sure as the cohort studies. That is, TCE is
identified as a specific exposure in only a few
studies. More often, it is captured as part ofa
more general class of exposures, such as
organic solvents. This likely leads to substan-
tial misclassification. Many ofthese studies
did identify dry cleaning and laundry work as
a specific exposure classification. However,
even with this categorization, there is likely
misclassification because many dry cleaners
typically had exposure to PERC, whereas
other dry cleaners and most (or all) laundry
workers were not likely to be exposed to TCE
or PERC.
In light of these exposure specification
issues, we rely most heavily on studies that
identify TCE exposure. Those listing organic
solvent exposure are less relevant, as exposure
likely included multiple solvents, some of
which are known or suspected carcinogens.
Those listing pre-1960 drycleaning and laun-
dries as an occupation or industry are subject
to the exposure concerns discussed above for
the Tier III cohort studies.
Community-BasedStudies
Community-based studies ofTCE exposure
are a set of investigations in which group
exposure is determined by place ofresidence
or water supply and in which there is limited
or no information on possible confounding
variables. In general, these are cross-sectional
studies ofcancers, often childhood cancers,
and drinking water contamination (85-99).
The study with the most sophisticated expo-
sure assessment, conducted in Finland, used
U-TCA, a biomarker ofTCE exposure in res-
idents, to assess the possible association of
drinking TCE-contaminated water and
cancer (87). In all the other studies, expo-
sures are inferred from measurements ofcont-
aminants in the drinking water source
(85,89,90) and/or numerical models provid-
ing estimates ofcontaminants in the water
(86,99), or proximity to hazardous waste sites
containingTCE (88,91-98)
These studies are ofparticular interest for
at least two reasons. First, these studies have
relatively high statistical power (i.e., the abil-
ity to detect an effect if one exists) even
though exposure levels are relatively low
because ofthe large number ofsubjects con-
suming the TCE-contaminated water.
Additionally, exposure in the drinking water
studies occurs by the oral route, in contrast to
the occupational studies in which inhalation
exposure is the primary route. It should be
noted, however, that a potential exists for
inhalation exposure in studies with contami-
nated drinking water due to the volatilization
ofTCE during showering and other uses.
Dermal absorption is a likely exposure route
in both these drinking water and the occupa-
tional studies but typically ofless importance
quantitatively.
These studies have a number oflimita-
tions. Like a number of the cohort studies
identified above, exposures typically are to
multiple solvents in community-based
studies, making it difficult to attribute
observed results to only one agent. Exposure
generally is assessed at a community level
rather than the individual. Contemporaneous
or retrospective assessment ofdisease relative
to exposure compromises their interpretabil-
ity. Adjustments for confounding typically
were limited, if conducted at all. Finally,
aggregation bias may be present in the analyses
in which groups are the unit ofanalysis.
CaeSeries
Finally, there are three reports in which
authors present data on cases without formal
analysis. Malek et al. (100) followed up 57
men who worked as dry cleaners in Prague
since the 1950s. Exposures assessed by
U-TCA were high (60% over 100 mg/L,
some near 1,000 mg/L). Three ofthe subjects
had lung cancer, one had tongue cancer, one
had rectal cancer, and one had both bladder
cancer and two rectal cancers. No informa-
tion about expected rates, confounders, or
other risks was provided.
Novotna et al. (101) reports a review of
the 63 liver cancer cases reported in Prague
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between 1972 and 1974. None had been
employed in workshops using TCE.
Similarly, Paddle (102) reports on 95 cases of
liver cancer in workers who live near a facility
manufacturing TCE, but none ofthem were
employed there.
These studies do not provide useful infor-
mation regarding the possible carcinogenicity
ofTCE, since it is not known whether these
cases represent the entire population at risk
or whether other risk factors differed among
the populations.
SitebySiteResults
Results for the cohort studies are shown in
Tables 4-9, for the case-control studies in
Tables 10-12, and for the community-based
studies in Table 13. We summarize the over-
all evidence in Table 14. Below we focus our
discussion on those cancer sites for which
there is the strongest evidence and those that
have been suggested byother studies.
Kidney cancer/renal cell carcinoma. The
evidence supporting ahypothesis ofan associ-
ation between TCE exposure and cancer is as
strong or stronger for the kidney than for any
other anatomical site. For kidney cancer, one
sees elevated risks across all study types except
community based, suggesting that kidney
cancer is associated with both TCE and dry
cleaning and laundry exposures. Most indi-
vidual study results are elevated for both inci-
dence and mortality across all tiers. In Tier I,
three offive SIRs and three offive SMRs are
elevated. The combined risk across Tier I
studies is elevated (for incidence RR = 1.7,
95% CI 1.1-2.7; for mortality RR = 1.2,
95% CI 0.8-1.7) and represents a substantial
number of individuals (21 cases and 37
deaths). Since 5-year survival is over 50%
(103) and many cases may die of other
causes, the incidence data are more relevant
than the mortality data. Exposure-response
patterns among the Tier I studies are
observed only in the studies ofMorgan et al.
(22) and Wong and Morgan (104) with
cumulative exposure to TCE (although the
number ofcases is small), and not in those of
Blair et al. (20), Boice et al. (21), or Anttila
et al. (24), which are the onlyotherstudies to
provide adequate information for exposure-
response consideration. All kidney cancers are
grouped in these studies, so that differentia-
tion between renal cell carcinoma and cancer
ofthe renal pelvis is not possible. Incidence
and mortality findings in the Tier II
(RR = 3.7; 95% CI 1.7-8.1; RR = 1.3, 95%
CI 1.0-1.7) and Tier III (RR = 0.9, 95% CI
0.7-1.2; RR = 2.3, 95% CI 1.5-3.5) studies
are elevated, also are based on substantial
numbers of cases and thus are supportive of
the Tier I study results.
The case-control studies provide support,
showing elevated risks for TCE, solvent, and
Table 4. Tier cohort SIRs: incidence.
Bladder
Brain
Breast
Buccal
Cervix
Colon
Esophagus
Hodgkin's
disease
Kidney
Larynx
leukemia
Liver
Liver/biliary
Lung
Lympho-
hematopoietic
Melanoma
Multiple
myeloma
Non-Hodgkin's
lymphoma
Pancreas
Prostate
Rectum
Skin
Stomach
Anttila et al.
(24)
0.8 (5)
(0.4-1.9)
1.1 (9)
(0.6-2.1)
2.4(8)
(1.2-4.8)
0.8(8)
(0.4-1.7)
1.7 (3)
(0.6-5.0)
0.9(6)
(0.4-1.9)
1.1 (5)
(0.5-2.5)
2.3(5)
(1.0-5.3)
0.9 (25)
(0.6-1.4)
1.5(20)
(1.0-2.3)
1.6(4)
(0.6-4.2)
1.8(8)
(0.9-3.6)
1.6(11)
(0.9-2.9)
1.4(13)
(0.8-2.4)
1.7 (12)
(1.0-3.0)
1.3(17)
(0.8-2.0)
Axelson etal.
(25)
1.0(8)
(0.5-2.0)
1.0(8)
(0.5-2.0)
1.0(1)
(0.5-6.0)
1.2 (6)
(0.5-2.5)
1.4(2)
(0.4-5.0)
1.4(4)
(0.6-3.6)
0.7 (9)
(0.4-1.3)
0.6(1)
(0.1-3.2)
1.6 (5)
(0.7-3.6)
0.3(1)
(0.0-1.4)
1.3 (26)
(0.8-1.8)
2.4(8)
(1.2-4.7)
0.7(5)
(0.3-1.6)
Blairetal. (20)
Male
1.4(9)
(0.5-4.1)
0.8(1)
(0.0-13.2)
0.8(7)
(0.3-2.2)
5.7 (23)
(1.9 -16.7)
0.4(2)
(0.1-2.3)
0.9 (4)
(0.2-3.7)
2.6(3)
(0.3-25.0)
1.1 (4)
(0.3-4.8)
0.8 (15)
(0.4-1.7)
1.4(17)
(0.7-2.9)
5.1 (5)
(0.6-43.7)
1.0(7)
(0.3-2.9)
0.7 (51)
(0.2-2.4)
1.2 (56)
(0.8-1.8)
2.0(6)
(0.5-8.1)
dry cleaning exposures, but inferences about
causation are less robust than the Tier 1
cohort studies due to limited exposure defini-
tion and potential biases (Table 10). Asal et al.
(60), Auperin et al. (67), Sharpe et al. (61),
and Vamvakas et al. (66) conducted hospital-
based case-control studies. Greenland et al.
(83), Lynge et al. (59), and Sinks et al. (12)
conducted case-control studies nested within
an occupational cohort. Dosemeci et al. (68),
Harrington et al. (57), Mandel et al. (64),
McCredie and Stewart (63), Mellemgaard et
al. (65), Partanen et al. (62), Schlehofer et al.
Blair etal. (20) Henschler
Female et al. (10)
1.0(1) -
(0.1-9.1) -
0.4(3) -
(0.1-1.2) -
0.9(3)
(0.3-3.2)
3.6(2)
(0.5-25.6)
0.9(3)
(0.2-3.3)
0.9(2)
(0.2-4.5)
1.0(1)
(0.1-10.9)
8.0(5)
(3.4-18.6)
Average risk
1.0 (23)
(0.6-1.6)
1.1 (10)
(0.6-2.0)
0.4(3)
(0.1-1.2)
0.8 (7)
(0.3-2.2)
2.4(8)
(1.2-4.8)
1.2(42)
(0.8-1.8)
0.0(0)
(0.0-0.0)
1.5(4)
(0.6-3.7)
1.7 (21)
(1.1-2.7)
1.4(2)
(0.4-5.0)
1.0 (9)
(0.5-2.1)
1.9(12)
(1.0-3.4)
1.1 (4)
(0.3-4.8)
0.8(49)
(0.6-1.1)
1.4(40)
(1.0-2.0)
0.0(0)
(0.0-0.0)
1.5(10)
(0.7-3.3)
1.5(22)
(0.9-2.3)
1.2(63)
(0.7-2.0)
1.3 (95)
(1.0-1.6)
1.7 (12)
(1.0-3.0)
2.4(8)
(1.2-4.7)
1.2(29)
(0.8-1.7)
(58), and Siemiatycki (84) conducted
population-based case-control studies. In all
of these studies, there are concerns about
selection bias, blinding of investigators or
interviewers, and particularly exposure charac-
terization. Some studies use job titles to infer
exposure (60,63,67), one compares dry clean-
ing workers to laundry workers (59), others
assess risk to subjects exposed to general
classes ofsolvents (57,63), and still other
studies askabout exposure to specificagents or
used more sophisticated exposure characteriza-
tions (58,61,62,64,66,68,83).
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Table 5. Tier cohort SMRs: mortality.
Blair et al.
(20)
Bladder 1.2(17)
(0.5-2.9)
Brain 0.8 (11)
(0.3-2.2)
Breast 1.8(20)
(1.0-3.3)
Buccal 1.4(9)
(0.4-5.2)
Cervix 1.8(5)
(0.5-6.5)
Colon 1.4(54)
(0.8-2.4)
Esophagus 5.6 (10)
(0.7-44.5)
Hodgkin's 1.4(5)
disease (0.2-12.0)
Kidney 1.6(15)
(0.5-5.1)
Larynx
Leukemia 0.6(16)
(0.3-1.2)
Liver 1.7 (4)
(0.2-16.2)
Liver/biliary 1.3(15)
(05-3.4)
Lung 0.9 (109)
(0.6-1.3)
Lympho- 1.1 (66)
hematopoietic (0.7-1.8)
Melanoma 1.0(9)
(0.3-3.1)
Multiple 1.3 (14)
myeloma (0.5-3.4)
Non-Hodgkin's 2.0 (28)
lymphoma (0.9-4.6)
Pancreas 1.2(33)
(0.6-2.3)
Prostate 1.1 (54)
(0.7-1.8)
Rectum 0.4(5)
(0.1-1.5)
Skin
Stomach 0.9(23)
(0.4-1.9)
Boice etal.
(21)
0.6(5)
(0.2-1.3)
0.5(4)
(0.2-1.4)
1.3(7)
(0.6-2.7)
0.6(5)
(0.3-1.4)
1.1 (30)
(0.8-1.5)
0.8(7)
(0.4-1.7)
2.8 (4)
(1.1-7.1)
1.0(7)
(0.5-2.0)
1.1 (4)
(0.4-2.8)
1.0(12)
(0.6-1.8)
0.5(4)
(0.2-1.4)
0.8(78)
(0.6-1.0)
0.5(2)
(0.1-1.7)
2.8 (4)
(1.1-7.1)
1.2 (14)
(0.7-2.0)
0.4(7)
(0.2-0.9)
1.0(32)
(0.7-1.5)
1.3(9)
(0.7-2.5)
0.8(7)
(0.4-1.7)
Elevated odds ratios for kidney cancer are
found for four different exposure classifica-
tions: degreasing agents (including TCE )
(60,61,66), solvents (61,63,65), the iron/
steel industry (likely including exposure to
degreasing agents or solvents) (58,62-65),
and dry cleaners/laundry workers (60,64,65).
A few studies assesses TCE exposure specifi-
cally (66,68,84). The Sinks et al. study (12)
characterizes renal cancer incidence by
department (or work process) for those
employed for 5 years or more. The finishing
department, where the TCE was most likely
Henschler
etal. (10)
3.7(1)
(0.7-20.6)
3.3(2)
(0.9-11.8)
1.4(7)
(0.7-2.9)
1.1 (1)
(0.2-6.1)
Morgan
et al. (22)
1.4(8)
(0.7-2.7)
0.6 (4)
(0.2-1.4)
0.8(16)
(0.5-1.2)
0.6(1)
(0.1-3.4)
1.3(8)
(0.7-2.6)
1.0(10)
(0.6-1.9)
1.0(6)
(0.5-2.1)
1.1 (97)
(0.9-1.3)
1.0(25)
(0.7-1.5)
1.0(14)
(0.5-1.7)
0.8(11)
(0.4-1.4)
1.2(21)
(0.8-1.8)
1.1 (6)
(0.5-2.3)
Ritz
(23)
1.2 (8)
(0.6-2.3)
1.3 (12)
(0.7-2.2)
1.0(9)
(0.6-2.0)
1.0(26)
(0.7-1.5)
1.2(9)
(0.6-2.3)
2.1 (6)
(1.0-4.5)
0.7(5)
(0.3-1.5)
1.2(5)
(0.5-2.8)
1.1 (12)
(0.6-1.9)
1.7 (8)
(0.8-3.3)
1.0 (112)
(0.9-1.2)
1.3 (37)
(0.9-1.8)
1.2(18)
(0.8-1.9)
1.4(24)
(0.9-2.1)
1.1 (7)
(0.5-2.2)
0.6(4)
(0.3-1.6)
1.4(15)
(0.8-2.3)
Average risk
1.1 (38)
(0.7-1.5)
0.9(32)
(0.6-1.4)
1.1 (43)
(0.8-1.5)
0.9(23)
(0.6-1.5)
1.8(5)
(0.5-6.5)
1.1 (110)
(0.9-1.4)
1.1 (26)
(0.7-1.8)
2.0(16)
(1.1-3.4)
1.2(37)
(0.8-1.7)
1.2(9)
(0.6-2.2)
1.0(50)
(0.7-1.3)
1.7 (4)
(0.2-16.2)
1.1 (33)
(0.7-1.7)
1.0 (403)
(0.9-1.1)
1.1 (129)
(0.9-1.4)
0.7(11)
(0.3-1.7)
1.9 (18)
(1.0-3.7)
1.2(56)
(0.9-1.7)
0.9(69)
(0.7-1.2)
1.2 (131)
(1.0-1.4)
1.0(27)
(0.7-1.6)
0.6(4)
(0.3-1.6)
1.1 (45)
(0.8-1.6)
to have been used, has three ofthe six reported
cases or renal cell carcinoma and a highly ele-
vated odds ratio (RR = 16.6, 95% CI
1.7-453.1).
The most recent and most striking renal
cell carcinoma case-control study, by
Vamvakas and colleagues (66), is hospital-
based using accident victims as controls. The
study was conducted in an area ofGermany
containing a large number ofmetal-working
shops usingTCE for degreasing purposes. The
authors report that exposure is principally to
TCE rather than to complex mixtures found
in many other studies. This investigation
reports a large and a statistically significant
(but relatively imprecise) elevated adjusted
odds ratio (OR) = 10.8, 95% CI 3.4-34.8)
with 19 exposed cases. Limitations include
the fact that the controls are not matched and
substantial demographic and behavioral dif-
ferences may exist between cases and controls,
raising questions ofcontrol selection bias, and
the source ofthe population is a hospital (i.e.,
Berkson's bias). The exposure data are col-
lected by personal interview conducted by
physicians, with possible recall bias and
reporting bias. Nonetheless, the difference
between this reported OR and the average
risk in the Tier I cohort studies is striking. It
may, in part, reflect differences in exposures
between biomarker studies (generally < 40
ppm) (18,24) and subjects in this study (66)
who experienced narcotic symptoms, which
can occur onlyat much higher exposure levels
[e.g., 200 mL/m3, Stopps and McLaughlin
(105) and Torkelson and Rowe (106)].
These findings are also supported by the
results ofDosemeci et al. (68).
Confounding and effect modification may
be important in interpreting these studies.
Devesa et al. report that cigarette smoking is
associatedwith higher risks for renal and blad-
der cancers (107). However, consideration of
other smoking related sites (e.g., lung) does
not reveal a strong smoking effect. Brownson
reports that cigarette smoking is an indepen-
dent risk factor for renal cancer, but alcohol
consumption is not (108). Potential con-
founding or modifying agents are not consid-
ered in most ofthe studies we review. None of
the community-based studies report on
kidneycancer incidence.
In summary, the cohort studies provide
strong evidence and the case-control studies
provide supporting evidence ofan association
between the incidence of kidney cancer
among workers exposed to degreasing agents
and solvents and to those in both the iron
and steel and dry cleaning and laundry work
industries. However, since most often expo-
sures are not measured, direct causality can-
not be assessed. Exposure-response data do
not add to this assessment. Failure to adjust
for confounding and effect modification also
mayaffect the results.
Liver andbiliary cancers. Studies ofliver
and biliary cancers also offer strong data in
support ofthe carcinogenicity ofTCE. Some
reports list liver and biliary cancers separately
and some combine them. Since we do not
have access to the raw data, we tabulate the
study results as published. Ofthe 16 cohort
studies reporting liver cancer, 3 report only
primary liver cancer, 5 report only liver and
biliary cancers combined, and 8 report liver
and biliary cancers separately. Nearly all the
case-control studies used only primary liver
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cancer cases. Therefore, for this discussion,
we use only primary liver cancer, where avail-
able, and combined liver and biliary other-
wise. Elevated liver cancer risks are found
across all study types except community-
based, and this finding supports the hypothe-
sis of an increased liver cancer risk due to
TCE exposure.
In the Tier I cohort studies, incidence is
elevated in all three studies reporting, none
statistically significantly, and mortality is ele-
vated in one of two studies reporting. The
average relative risk for the incidence ofliver
cancer is elevated (RR = 1.9, 95% CI
1.0-3.4), although only exposed 12 cases
were reported. The average relative risk of
dying from liver and biliary cancer is slightly
elevated (RR = 1.1, 95% CI 0.7-1.7) for 33
deaths. Evidence is strongest for an associa-
tion in the cohort biomarker study by
Anttila et al. (24) that isolated TCE, where a
statistically significantly elevated liver cancer
risk is observed among individuals with the
longest time since first exposure. This may be
due to higher historical exposure or to
allowance for latency. Additional support for
an association is provided by the positive
exposure response gradients with both cumu-
lative exposure and with time since first expo-
sure in the Anttila study. Ritz shows data
indicating an increased risk ofmortaity for
increased exposure and increased duration of
exposure (23). Data from Boice et al. do not
show an exposure-response relationship (21).
In the Tier II studies, 3 of 5 report that
relative risks are greater than 1.0 for liver or
biliary cancer. The average risk for liver cancer
only, based on 15 exposed cases, is more ele-
vated (RR = 2.0, 95% CI 1.3-3.3) than that
for liver and biliary cancers combined
(RR = 1.3, 95% CI 1.0-1.8), based on 34
cases. Findings from studies ofdry cleaners
and laundry workers (Tier III studies) are
more ambiguous, showing elevated incidence
for liver cancer alone and liver and biliary can-
cers but depressed mortality for liver and
biliary cancers combined. These results may
reflect lack ofexposure specificity. Females in
one study show elevated risks for liver and
combined liver and biliary cancer incidence
(40), while four other studies show slightly
depressed risk ofmortality. The study with
the elevated rates among females had more
cases (i.e., 14 incident cases) than the other
four studies combined (i.e., 11 deaths). The
relationship between work as a dry cleaner or
laundry worker and liver cancer is not clear,
although this observation is limited by the sta-
tistically small number ofliver cancer cases
anddeaths.
The results ofthe case-control data are
reported in Table 11. Most studies assess
organic solvents generically or dry cleaning
and laundries, limiting interpretability with
Table 6. Tier II cohort SIRs: incidence.
Shannon etal. (11) Shannon etal. (11)
Male Female Sinks et al.(12) Average risk
Bladder 0.9 (3) - 1.1 (3) 1.0(6)
(0.3-2.7) - (0.4-3.1) (0.5-2.1)
Breast - 2.0 (8) - 2.0 (8)
- (1.0-4.0) - (1.0-4.0)
Cervix - 1.1 - 1.1 (1)
- (0.2-5.9) - (0.2-5.9)
Kidney - 3.7 (6) 3.7 (6)
-- (1.7-8.1) (1.7-8.1)
Lung 0.6 (6) - - 0.6 (6)
(0.3-1.3) - - (0.3-1.3)
Prostate 1.6(7) - - 1.6 (7)
(0.8-3.2) - - (0.8-3.2)
respect to TCE exposure. Results are mixed
for each ofthese exposures.
Few of the studies reviewed provide
information about confounding variables or
effect modifiers. Interactions in the metabolic
system have been found between TCE and
alcohol consumption (109,110). Hernberg et
al. (73), however, found alcohol consump-
tion to be a negative confounder in a study of
liver cancer and solvent exposure. Failure to
adjust for these and similar effects could
affect inferences. However, data availability
precluded adjustments for this evaluation.
One community-based study reports
results for liver cancer (87). That study, con-
ducted in Finland, reports lower rates ofliver
cancer in both municipalities' studies from
1953 to 1991 than expected based on
national data.
In summary, results suggest that workers
with solvent exposure are likely to be at excess
risk ofliver cancer, although specific exposure
information and exposure-response gradients
arewanting.
Non-Hodgkin's lymphoma. Elevated non-
Hodgkin's lymphoma risks are found in the
Tier I, case-control, and community-based
studies supporting the hypothesis that TCE
exposure is associated with cancer at this site.
Two of four Tier I reports have elevated
incidence of non-Hodgkin's lymphoma
(although the two for which it was not ele-
vated were the gender-specific rates from the
same study). The average incidence rate is ele-
vated (RR = 1.5, 95% CI 0.9-2.3) and is
based on 22 cases. Mortality is elevated in
two of three reports, with an average of
RR = 1.2, 95% CI 0.9-1.7 based on 56
deaths. Risks appear to increase with increas-
ing latency (time since first exposure) in the
biomarker study ofAnttila et al. (24) and
with mean exposure in Axelson et al. (18).
There is no clear exposure-response pattern
in the Boice et al. data (21).
Results ofTier II and Tier III studies are
considered null in that there was only weak
evidence for an association and results are
based on 8 incident cases and 20 deaths.
Again, this may be due in part to the less
robust definition ofexposure in these studies
compared to that in theTier I studies.
The findings from the case-control
studies (54-56,78-80,83,84) shown in Table
12 add further support for an association
between solvents, specifically TCE, and non-
Hodgkin's lymphoma. Six ofseven studies
showed elevated ORs, two were statistically
significant, and several reported TCE (rather
than general solvent) exposure.
Similarly, findings from two community-
based studies support an association between
non-Hodgkin's lymphoma and drinking
water exposure although the mixed solvent
exposures in these studies make this result
difficult to interpret.
Hodgkin's disease. Elevated risks for
Hodgkin's disease are found for incidence
and mortality in the Tier I studies, mortality
in Tier III studies, and case-control studies,
with solvent exposures supporting a possible
TCE-related etiology. In Tier I, both bio-
marker studies report excess incidence,
although case numbers are very low, and
three offour mortality studies report excess
risk. In Tier II, only one offive studies shows
excess mortality risk, although again, case
numbers are very small. In Tier III, only one
study reports on Hodgkin's disease, but it
shows excess mortality risk. The three
case-control studies (Table 12), all with sub-
stantial numbers ofcases, show risks between
2.8 and 6.8. Only one community-based
study reports on Hodgkin's disease, with
mixed results for two communities (87).
Overall, these results are suggestive.
Cervical cancer. Cervical cancer,
although sparsely reported, is elevated in Tier
I, Tier II, and Tier III studies. The average
risk in Tier III mortality studies, the only tier
with more than one studywith the same type
of outcome, is depressed for incidence
(RR = 0.8, 95% CJ 0.6-1.2) and elevated for
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Table 7.Tier II cohort SMRs-mortality.
Blair etal.
(27)
Bladder 0.5(2)
(0.1-1.8)
Brain 1.7 (5)
(0.7-4.0)
Breast
Buccal 0.8(3)
(0.3-2.4)
Cervix
Colon 1.4(16)
(0.9-2.3)
Esophagus 0.7 (2)
(0.2-2.6)
Hodgkin's 0.8(1)
disease (0.1-4.6)
Kidney 1.1 (3)
(0.4-3.1)
Larynx 0.6(1)
(0.1-3.2)
Leukemia 1.5(7)
(0.8-3.2)
Liver 1.1 (3)
(0.4-3.3)
Liver/biliary
Lung 0.5(18)
(0.3-0.8)
Lympho- 1.6(17)
hematopoietic (1.0-2.5)
Melanoma
Multiple -
myeloma -
Non-Hodgkin's -
lymphoma -
Pancreas 0.6(4)
(0.2-1.6)
Prostate 1.1 (10)
(0.6-2.0)
Rectum 1.2(5)
(0.5-2.8)
Skin 1.6(3)
(0.5-4.6)
Stomach 0.5(4)
(0.2-1.4)
Blair etal.
(28)
1.0 (8)
(0.4-2.0)
1.1 (7)
(0.4-2.2)
1.5(11)
(0.7-2.6)
1.1 (23)
(0.7-1.7)
1.9(10)
(0.9-3.4)
1.4(5)
(0.5-3.3)
1.1 (6)
(0.4-2.4)
1.4(5)
(05-3.3)
0.6(6)
(0.2-1.3)
2.8(5)
(0.9-6.5)
1.6(10)
(0.8-3.0)
1.1 (62)
(0.6-1.4)
1.4(8)
(0.6-2.7)
1.3 (17)
(0.8-2.1)
1.1 (19)
(0.7-1.7)
1.2(11)
(0.6-2.2)
0.8(14)
(0.5-1.4)
mortality (RR = 1.7, 95% CI 1.5-2.0) based
on 34 and 43 cases, respectively. In the
Anttila et al. study (24), there is an
exposure-response relationship. Most
case-control studies on cervical cancer do
not address relationships with solvent expo-
sure or dry cleaning. The association
observed in the cohort studies may be
explained by confounding from socioeco-
nomic status or other lifestyle factors. In
addition, there is good evidence from other
studies of a viral etiology (111). However,
the data in this review are sufficiently com-
Dubrowand Gute (29)
Male Female
1.0 (13) 0.9(3)
(0.6-1.8) (0.2-2.6)
1.0 (9) 1.5(17)
(0.5-1.9) (1.0-2.4)
- 0.9 (66)
_ (0.7-1.1)
0.6 (7) 1.3 (6)
(0.3-1.3) (0.5-2.9)
- 1.2 (13)
- (0.7-2.0)
1.3 (43) 0.9 (39)
(1.0-1.8) (0.6-1.2)
0.4(3) 0.8 (3)
(0.1-1.1) (0.2-2.3)
0.6 (2) 0.3 (1)
(0.1-2.1) (0.0-1.7)
1.6(11) 1.8(8)
(0.9-2.8) (0.8-3.4)
1.1 (6) -
(0.5-2.4) -
1.0(10) 1.0 (9)
(0.5-1.8) (0.5-1.9)
3.0 (6) 0.4(1)
(1.1-6.5) (0.0-2.4)
2.0 (10) 0.8 (6)
(1.0-3.7) (0.3-1.7)
1.0(89) 1.3(46)
(0.8-1.2) (1.0-1.7)
1.1 (4) 1.0 (4)
(0.3-2.9) (0.3-2.6)
1.0 (8) 0.4(4)
(0.5-1.9) (0.2-1.1)
0.8(12) 1.0(15)
(0.5-1.4) (0.6-1.7)
0.7(18) -
(0.4-1.1) -
0.7 (8) 1.1 (11)
(0.3-1.3) (0.6-1.9)
1.2(20) 1.7 (20)
(0.8-1.8) (1.1-2.7)
Garabrant
et al. (30)
1.3(17)
(0.8-2.0)
0.8(13)
(0.5-1.3)
0.9(16)
(0.6-1.5)
0.6(10)
(0.3-1.1)
0.9 (47)
(0.6-1.3)
1.1 (14)
(0.7-1.9)
0.7(4)
(0.3-1.9)
0.9(12)
(0.5-1.6)
0.8(16)
(0.5-1.3)
0.9(8)
(0.5-1.9)
0.8(138)
(0.7-1.0)
0.8(38)
(0.6-1.1)
Sinks etal.
(12) Average risk
2.6(1)
(0.5-14.7)
1.4(1)
(0.3-7.7)
1.2(34)
(0.8-1.7)
0.9(25)
(0.6-1.4)
1.0(15)
(0.6-1.7)
0.7(7)
(0.3-1.5)
0.4(9)
(0.2-0.8)
1.1 (44)
(0.8-1.5)
1.2(51)
(0.9-1.5)
0.9 (82)
(0.7-1.1)
0.9(37)
(0.7-1.3)
1.2 (13)
(0.7-2.0)
1.1 (168)
(0.9-1.3)
1.1 (32)
(0.8-1.6)
0.8(13)
(0.5-1.4)
1.3(41)
(0.9-1.7)
1.2 (12)
(0.7-2.0)
0.9(48)
(0.7-1.2)
2.0(15)
(1.3-3.3)
1.3 (34)
(1.0-1.8)
0.9 (353)
(0.8-1.0)
1.0 (55)
(0.7-1.3)
0.0(0)
(0.0-0.0)
1.1 (8)
(0.6-2.1)
0.9(20)
(0.6-1.4)
1.1 (82)
(0.9-1.3)
0.9(72)
(0.7-1.2)
1.0(50)
(0.8-1.3)
0.9(10)
(0.5-1.7)
1.0(67)
(0.8-1.3)
pelling in implicating solvent exposure that
theywarrant furtherstudy.
Pancreatic cancer. Pancreatic cancer
results are mixed in the Tier I and II studies
but more consistent and stronger in the dry
cleaning and laundry worker (Tier III)
studies. The average RRs in the Tier III
studies for incidence (RR= 1.7, 95% CI
1.2-2.6) and mortality (RR- 1.3, 95% CI
1.0-1.7) are both elevated based on 22 and
42 cases, respectively. Since the average 5-year
survival for people with pancreatic cancer is
below 5% (103), incidence and mortality are
ofcomparable validity as measures ofeffect.
There is evidence for a protective effect from
the case-control studieswith solvent exposure
(82,83), evidence for cancer risk with TCE
exposure (83), and evidence for cancer risk
with drycleaning andlaundrywork including
an exposure-response relationship (81). Since
the effect is strongest in Tier III studies and
also seen in dry cleaner and laundry worker
studies, this outcome is likely to be linked to
dry cleaner exposures. However, the lack of
more defined exposure assessments in the dry
cleaner studies precludes drawing conclusions
about a specific solvent. Random variation is
another possible but unlikely explanation for
the observed results. The evidence for an
association between TCE exposure and pan-
creatic cancer is null to weak for TCE but
moderate fordrycleaner exposures.
Othercancers. The cohort studies provide
weak supportive data of an association
between TCE exposure and multiple
myeloma, and prostate and ski cancers.
Further data and study are needed to be able
to make anyinferences.
The leukemia results ofthe case-control
and community-based studies are intriguing.
The studies conducted ofchildren in Woburn,
Massachusetts, provide particularly thorough
evaluation, with the most recent studies
explaining the leukemias in children born after
the contaminated wells were closed by docu-
menting in utero exposures (86,99,112). Of
the community-based studies conducted in six
different regions, all but one ofthe regions
have an excess incidence ofleukemia in at least
one gender. Unfortunately, inferences regard-
ing TCE and leukemia are limited because
these drinking water/hazardous waste site
studies are not sufficiently specific to a single
causative agent and generally do not adjust for
confounding factors. The results are not sup-
ported by the cohort studies that show little
evidence ofleukemia risk from TCE exposure.
However, we suggest that in light ofthe pre-
ponderance ofexcess leukemia in these drink-
ing water/hazardous waste site studies, it is
important to determine the likely risk factor
for this disease, be it TCE, some other com-
pound in the drinking water (e.g., tri-
halomethanes), some other factor, or some
combination offactors.
Two sites that show strong associations
with dry cleaning and laundry work but not
TCE exposure are bladder and esophageal
cancers. Bladder cancer is elevated in the most
well-designed cohort studies ofdry cleaners
(15,39) and in only one ofthe three studies
reporting on dry deaners and laundryworkers
together. On average, the risk was statistically
significantly elevated. This increased risk of
bladder cancer is also supported in the
case-control studies (42-45). Esophageal
cancer is elevated in the two dry cleaner
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cohorts reporting this outcome (15,39) and
elevated in one case-control study (49). An
excess of esophageal cancer is not found
among laundry workers, a population similar
to dry cleaners butwithout exposure to PERC
(53). These observations suggest that PERC is
the likelyetiologic agent forboth ofthese out-
comes but warrant further investigation for
confirmation and to adjust for other known
riskfactors forcancer at these sites.
SummaryofResults
A summary ofresults is provided inTable 14.
The cancer sites are ordered by those showing
evidence in animal studies, followed by those
showing evidence in Tier I cohort studies,
followed by the other sites examined. Sites
showing statistically significant average risks
are denoted with "+++"; those with average
risks above 1.2, with "+"; those within the
range from 0.8 to 1.2, by "0", and those
below 0.8, by "-". "H" is used to signify sub-
stantial variation among the studies. Sites that
show the most consistent and compelling
results with respect to TCE exposure and
cancer are the kidney and liver. The next
most compelling results with respect to TCE
exposure are for Hodgkin's disease, non-
Hodgkin's lymphoma, and cervical cancer.
For dry cleaners and laundry workers, pre-
sumably due to PERC exposure, the most
compelling results are found for kidney, liver,
cervical, lung, esophageal, and pancreatic can-
cers and multiple myeloma. Weaker results
were found for laryngeal, colon, and prostate
cancer with TCE exposure, and for bladder
cancer among TCE-exposed dry deaners and
laundryworkers.
In general, exposure-response gradients
are observed in two or more studies for can-
cers of the kidney, liver, and specific lym-
phatic tissues. The overall effects are
moderate but consistent across studies.
Discussion
At the outset, it is important to note some of
the limitations ofour analysis. First, we rec-
ognize that the summary relative risks we
report for each tier ofcohort studies is highly
dependent on the selection of cohorts for
each tier. We do include in our analysis all
cohorts that report data by anatomical site.
The three-tier classification scheme we use is
based on our assessment ofthe quality ofthe
exposure data for TCE-exposed workers.
Second, as noted above, the exposure
information available is rather crude and does
not isolate TCE. The crude exposure infor-
mation most likely biases results toward the
null. The failure to isolate TCE from other
occupational exposures, including other sol-
vents, could bias the results in either direc-
tion. Ofparticular concern is the possibility
that exposures from different solvents are
Table8.Tier Ill cohortSIRs: incidence.
Bladder
Brain
Breast
Buccal
Cervix
Colon
Esophagus
Hodgkin's
disease
Kidney
Larynx
Leukemia
liver
liver/biliary
Lung
Lympho-
hematopoietic
Melanoma
Multiple
myeloma
Non-Hodgkin's
lymphoma
Pancreas
Prostate
Rectum
Skin
Stomach
Lynge and
Thygesen (40)
Male
0.6 (6)
(0.2-1.3)
1.5(5)
(0.5-3.5)
1.4(10)
(0.7-2.7)
1.5(6)
(05-3.3)
0.7 (2)
(0.1-2.6)
0.5(1)
(0.0-2.5)
1.1 (28)
(0.8-1.7)
1.0(2)
(0.1-3.6)
3.3(4)
(0.9-8.5)
2.8(5)
(0.9-6.5)
2.4(9)
(1.1-4.5)
1.4(11)
(0.7-2.6)
1.4(9)
(0.6-2.6)
1.0 (14)
(0.5-1.6)
1.3 (7)
(0.5-2.7)
Lynge and
Thygesen (40)
Female
0.9(8)
(0.4-1.7)
1.0(12)
(0.5-1.8)
0.8 (94)
(0.7-1.0)
0.8 (34)
(0.6-1.2)
0.9 (25)
(0.6-1.4)
0.6 (5)
(0.2-1.4)
0.7 (5)
(0.2-1.7)
3.3 (7)
(1.3-6.9)
2.0(14)
(1.1-3.4)
1.3 (32)
(0.9-1.8)
0.7 (8)
(0.3-1.3)
1.1 (3)
(0.2-3.1)
0.5(3)
(0.1-1.5)
1.4(13)
(0.7-2.4)
0.7(11)
(0.4-1.3)
0.7 (31)
(0.5-1.0)
1.3(11)
(0.6-2.3)
correlated with one another and one ofthe
others maybe carcinogenic.
Third, we note that fewofthe more tradi-
tional confounding variables (e.g., smoking,
alcohol consumption) are assessed in any
study. We believe it unlikely that adjustment
for these factors would result in substantial
changes in the reported risks but cannot rule
it out.
Fourth, there is only limited exposure-
response data, which limits our ability to
make inferences.
McLaughlin
et al. (38)
Male
1.0(18)
(0.6-1.6)
McLaughlin
etal. (38)
Female
0.9 (25)
(0.6-1.3)
Average risk
0.8(14)
(0.5-1.3)
1.1 (17)
(0.7-1.8)
0.8 (94)
(0.7-1.0)
0.0(0)
(0.0-0.0)
0.8(34)
(0.6-1.2)
1.1 (35)
(0.8-1.5)
0.0(0)
(0.0-0.0)
0.0 (0)
(0.0-0.0)
0.9(54)
(0.7-1.2)
0.0(0)
(0.0-0.0)
0.7 (7)
(0.4-1.5)
3.3(7)
(1.6-6.90)
1.8(15)
(1.1-2.9)
1.2 (60)
(0.9-1.6)
0.0(0)
(0.0-0.0)
0.7 (10)
(0.4-1.3)
2.0(7)
(1.0-4.1)
1.4(8)
(0.7-2.8)
1.7(22)
(1.2-2.6)
1.4(11)
(0.8-2.6)
1.0 (20)
(0.6-1.5)
0.8(45)
(0.6-1.1)
1.3(18)
(0.8-2.0)
Fifth, the occurrences ofthe diseases stud-
ied are relatively rare, limiting the sensitivity
of the studies reviewed. In short, there are
many limitations to the set ofstudies that we
consider in this review. Nonetheless, we
believe that there is substantial consistency
across studies, which suggests that it is
unlikely that any ofthese concerns have a
substantial effect on our analysis.
Others view the consideration of the
possible carcinogenicity ofTCE as a contro-
versial topic. In addition to several reviews
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Table 9.Tier IV cohort SMRs: mortality.
Blair etal.
(39)
Bladder 1.7 (8)
(0.9-3.3)
Brain 0.2 (1)
(0.0-1.2)
Breast 1.0 (36)
(0.7-1.4)
Buccal 1.0 (5)
(0.5-2.2)
Cervix 1.7 (21)
(1.4-2.0)
Colon 1.0(25)
(0.7-1.4)
Esophagus 2.1 (13)
(1.2-3.6)
Hodgkin's 2.1 (4)
disease (0.8-5.3)
Kidney 0.5 (2)
(0.1-1.8)
Larynx 1.6 (3)
(0.5-4.7)
Leukemia 0.9(7)
(0.4-1.8)
Liver
Liver/biliary 0.7 (5)
(03-1.7)
Lung 1.3(47)
(1.0-1.7)
Lympho- 1.2 (24)
hematopoietic (0.8-1.8)
Melanoma
Multiple
myeloma
Non-Hodgkin's
lymphoma
Pancreas 1.2 (15)
(0.8-1.9)
Prostate 0.7 (5)
(0.3-1.7)
Rectum 1.4(10)
(0.8-2.5)
Skin 0.8(2)
(0.2-2.8)
Stomach 0.8 (11)
(0.5-1.4)
Duh and Asal
(36)
0.4(1)
(0.1-2.8)
0.1 (1)
(0.0-0.4)
0.5(1)
(0.1-3.4)
1.3(2)
(0.3-5.3)
0.6)7)
(0.3-1.2)
3.8 (7)
(1.9-7.6)
0.5(1)
(0.1-3.5)
1.7 (37)
(1.2-2.5)
0.5(3)
(0.1-1.7)
0.8(4)
(0.3-2.4)
0.9(2)
(0.2-3.5)
1.5(2)
(0.4-6.1)
0.8)3)
(0.3-2.5)
Katz and Jowett
(35)
1.9 (5)
(0.6-4.4)
0.7 (27)
(0.5-1.0)
2.0 (10)
(0.9-3.6)
1.0(21)
(0.6-1.6)
2.6 (7)
(1.0-5.3)
0.7 (4)
(0.2-1.7)
0.9 (4)
(0.2-2.3)
1.0 (10)
(0.5-1.8)
1.2(9)
(0.5-2.2)
1.2 (6)
(0.4-2.6)
2.1 (4)
(0.6-5.3)
0.3(2)
(0.0-1.2)
that have been published in the peer-
reviewed literature, two expert panels have
reviewed TCE. In a 1992 report, the
American Conference of Governmental
Industrial Hygienists, examining animal and
epidemiologic studies, concludes that the
evidence indicated no carcinogenic risk, and
places TCE in their category A5, not car-
cinogenic to humans (113). Several years
later, IARC, looking at both occupational
exposures and drinking water exposures,
classifies TCE as probably carcinogenic to
humans (Group 2A) based on "limited"
Ruder et al. (15)
Male Female
3.3 (7)
0.6-6.7)
2.1 (5)
(0.9-5.0)
1.4 (9)
(0.7-2.6)
1.6(5)
(0.7-3.7)
0.7(1)
(0.1-3.7)
0.8(1)
(0.1-4.6)
0.5(1)
(0.1-3.6)
1.3 (31)
(0.9-1.8)
0.9(5)
(0.4-2.0)
1.7(7)
(0.8-3.5)
0.8(7)
(0.4-1.7)
1.0(2)
(0.3-3.8)
0.4(2)
(0.1-1.5)
human evidence
evidence (13).
1.4(2)
(0.4-5.1)
1.1 (19)
(0.7-1.7)
0.8(1)
(0.1-4.3)
1.8(10)
(1.0-3.3)
1.7 (17)
(1.1-2.7)
3.2(5)
(1.4-7.6)
2.4(3)
(0.8-7.0)
2.9(1)
(0.5-16.3)
0.8 (2)
(0.2-2.7)
1.0(12)
(0.5-1.8)
0.6 (4)
(0.2-1.4)
1.6(8)
(0.8-3.2)
1.5 (3)
(0.5-4.3)
0.9 (3)
(0.3-2.5)
Average risk
2.0 (23)
(1.3-2.9)
0.2(1)
(0.0-1.2)
0.9(83)
(0.7-1.1)
1.2(12)
(0.7-2.1)
1.7 (43)
(1.5-2.0)
1.1 (79)
(0.9-1.4)
2.2 (23)
(1.5-3.2)
2.1 (4)
(0.8-5.3)
2.3 (20)
(15-3.5)
1.6(5)
(0.7-3.5)
0.8(13)
(0.5-1.3)
0.0(0)
(0.0-0.0)
0.7(11)
(0.4-1.3)
1.3 (137)
(1.1-1.5)
1.0(33)
(0.7-1.4)
0.0(0)
(0.0-0.0)
0.0(0)
(0.0-0.0)
0.0(0)
(0.0-0.0)
1.3(42)
(1.0-1.7)
0.8 (16)
(0.5-1.3)
1.3 (23)
(0.9-1.9)
1.5(8)
(0.8-2.9)
0.7 (21)
(0.5-1.0)
and "sufficient" animal
Henschler and colleagues (114), in a
letter responding to a vitriolic attack by
Bloemen and Tomenson (115) and Swaen
(116) about the design of their study (10),
calculate the combined OR among six
case-control studies (60-64,83) assessing the
association between occupational risk factors
and renal cell cancer. They find statistically
significantly elevated average rates for those
working in the iron and steel industry and
related professions where TCE and PERC are
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used for metal degreasing (OR= 1.49, 95%
CI = 1.19, 1.86) and for those exposed to
PERC used as a dry cleaning solvent
(OR=1.49, 95% CI = 1.24, 1.80). They con-
clude that TCE exposure does pose a risk of
kidney cancer.
McLaughlin and Blot (116) subsequently
review the epidemiology ofTCE and kidney
cancer in seven cohort studies (10,18,19,24,
30,31,104) and six case-control studies
(57,60-62,83,84) In their discussion, they fail
to distinguish results either between men and
women or incidence and mortality, and argue
that none of the cohort studies except "the
methodologically questionable" Henschler et
al. study (10) show a relationship between
TCE and kidneycancer risk. We note that the
updates oftwo ofthe studies were published
after that review and, as noted above, show
weakly positive associations, as does the study
ofSinks et al. (12,32), which was omitted.
McLaughlin and Blot also argue that the
case-control studies do not show support for
the hypothesized association.
Weiss (6) also reviews the occupational
epidemiology ofTCE exposure, concentrat-
ing on only four studies (all of which are
Tier I studies): the Blair et al. NCI-based
study ofaircraft maintenance workers (20),
the Axelson et al. Swedish worker study
(18), the Anttila et al. Finnish worker study
(24), and an early version ofthe Wong and
Morgan study of the Hughes Aircraft
employees (104). Weiss suggests that the
data provide only weak support for carcino-
genicity ofTCE, and then only for liver and
biliary tract cancers, kidney cancers, and
non-Hodgkin's lymphoma. He argues that
the rarity ofdisease among these cohorts (23
kidney cancer cases; 16 liver cancer cases; 12
biliary cancer cases; 33 non-Hodgkin's lym-
phoma cases), the relatively small relative
risks, and the lack of clear exposure-
response data are too limited to infer causal-
ity. Using the most recent reports in the
Tier I studies, we found 51 cases of kidney
cancer (21 incident; 37 deaths), 16 cases of
liver cancers (12 incident; 4 deaths), 37 bil-
iary cancers combined (4 incident; 33
deaths), and 78 cases ofnon-Hodgkin's lym-
phoma (22 incident; 56 deaths), a more
than doubling of cases over those reported
by Weiss except for liver cancer (for which
no new studies were used).
Morgan and colleagues (22) in their
report of their own study also combine their
results with those ofAnttila et al. (24),
Axelson et al. (18), and Spirtas et al. (19).
They note slightlyelevated but not statistically
significant SMRs for liver, prostate, kidney
and bladder cancers and non-Hodgkin's lym-
phoma (SMRs 1.1-1.3). They, too, conclude
that the interpretation ofcausality is compro-
mised due to the small number ofcases.
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Table 10. Casecontrol studies: kidneycancer.
Exposure Numberofsubjects Participation rate Odds ratio
Reference assessment Exposureclassification (cases/controls) (cases/controls),% (95% Cl) Exposure response
Asal et al. (60) Occupation DC(male) 315/313+336 - 0.7(0.2-2.3)
DC (female) (hospital +population) 2.8(0.8-9.8)
Metal degreasing 1.7(0.7-3.8)
Auperin etal. (67) Occupation Drycleaning 196/347 99/99 Toofewexposed
Dosemeci etal. (68) Occupation TCE(male) 273/462 86 1.0(0.6-1.7)
from interview TCE(female) 165/225 86 2.0(1.0-4.0)
toJEM TCE(total) 438/687 86 1.3(0.9-1.9)
Greenland etal. (83) JEM TCE asdegreaser 1,821/1,202 75/64 1.0(0.3-3.3)
Harrington etal. (57) Questionnaire Solvent exposure 54/54 53/? 1.0(0.2-4.9)
No exposed cases
Lynge etal. (59) Occupation Drycleaning 16/80 ? 0.7(0.2-3.6)
Mandel etal. (64) Interview DC industry(male) 1,732/2,309 72/75 0.9(0.3-2.4) None
DC solvents (male) 1.4(1.1-1.7)
DC solvents(female) 1.6(1.0-2.7)
Iron/steel industry(male) 1.6(1.2-2.2)
McCredie and Interview DC industry 489/523 91/74 2.7(1.1-6.7) Trend inyears
Stewart(63) Solvent exposure 1.5(1.1-2.1) workedforiron/
Iron/steel industry 1.2(0.8-1.9) steel industry
Mellemgaard etal. (65) Interview DC(male) 368/396 86/78 2.3(0.2-27.0)
DC(female) 2.9(0.3-33.0)
Solvents(male) 1.5(0.9-2.4)
Solvents(female) 6.4(1.2-23.0)
Iron/steel industry (male) 1.4(0.8-2.4)
Partanen et al. (62) Mail survey DC, solvents 338/338 69/68 Toofewexposed
Iron/metalwork 1.9(0.9-3.8)
Schlehofer etal. (58) Interview PERC 277/286 85/75 2.5(1.2-5.2)
Metal industry 1.6(1.1-2.5)
Sharpe etal. (61) Mail survey Organic solvents 164/161 97 1.7(0.9-3.2)
Degreasing solvents 3.4(0.9-12.7)
Siemiatycki (84) TCE(2% prevalence) 3,730/533 78 0.8(0.4-2.0) None
Sinks etal. (12) Job history TCE and solvents 6/48 21.7(3.0-inf)
Vamvakas (66) Medical doctor TCE and PERC(PERC 58/84 79/75 10.8(3.4-34.8) Weakevidence
interview in controls only)
DC,drycleaning.
Table 11. Case-control studies: liver cancer.
Exposure Exposure Numberofsubjects Participation rate Odds ratio Exposure Reference assessment classification (cases/controls) (cases/controls), % (95% Cl) response
Austin etal. (74) Interview DC 80/146 - 0
(only4exposed
controls)
Greenland et al. (83) JEM TCE as degreaser 1,821/1,202 75/64 0.5(0.1-2.6) LB
Hardell etal. (71) Mail survey Solventexposure 102/200 99/97 1.8(1.0-3.4) PLC
2.1 (1.1-4.0) HCC -
Hernberg etal. (73) Mail surveyand IH Solventexposure 377/385 72/71 0.6(0.3-1.3)m, PLC
(TCE, PERC, CCI4) 3.4(1.3-8.6)f, PLC
Hernberg etal. (72) Mail surveyand IH Solvent exposure 126/175 /62% 2.3(0.8-7.0) PLC Mainly
women
Houton and Sonnesso(70) Interview DC 102/ - Toosmall toassess;
2 cases in DC
Lynge etal. (59) Occupation DC 17/85 100/97 Noexposedcases
Stemhagen etal. (69) Interview DC 265/530 79/77 2.5(1.0-6.1) PLC
2.3(0.9-6.1) HCC
Environmental Health Perspectives
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Suarez et al.(75) Death certificate DC 1,742/1,742 - 1.0(0.4-2.2) PLC
Abbreviations: HCC, hepatocellular cancer; LB,liverandbiliary cancer; PLC,primary liver cancer.
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The newest data on kidney cancer
suggest different interpretations, although
Weiss (6) and McLaughlin and Blot (117)
caution the reader on the interpretation of
these results because the Tier I cohort
studies they had available showed, at best, a
weak response. They also suggest exclusion
ofthe Henschler et al. study (10) because it
was a follow-up from a cluster report, a
judgment with which we disagree. We
found that updates of two Tier I cohorts
(20,22) show positive results as do some
additional case-control results. With these
additional data, the association is even more
convincing to us, although we are still
plagued by our inability to isolate TCE expo-
sure from PERC exposure. One also must
note the low exposures reported in most of
the Tier I cohort studies, which may limit
the resolving power of these studies but not
the importance ofthe observed association.
Table 12. Case-control studies: lymphoma.
Number of subjects Participation rate, Odds ratio Exposure
Reference Exposure assessment Exposure classification (cases/controls) cases/controls, % (95% Cl) response
Hodgkin's Disease
Hardell et al. (54) Survey TCE, PERC, styrene, benzene 169/338 - 4.6(1.9-11.4)
(Hodgkin's and
non-Hodgkin's)
Olsson and Brandt(56) Interview Organic solvents (2 with TCE reported) 25/50 - 6.8(1.8-23.8)
Persson et al. (55) Survey TCE 54/275 Hodgkin's 96/83 2.8(1.1-7.2)
Non-Hodgkin's lymphoma
Blair etal. (80) Interview Occupation/JEM 622/1245 87/80 1.1(0.9-1.4) Positive for
Nonbenzene solvents intensity
Greenland etal. (83) JEM TCE as degreaser 1,821/1,202 75/64 0.8 (0.2-2.4)a -
Figgs etal. (79) Death certificate Occupation: aircraftmechanics 23,890/119,450 - 2.5(1.1-6.0) -
Hardell et al. (54) Survey TCE, PERC, styrene, benzene 169/338 - 4.6(1.9-11.4) -
(Hodgkin's and
non-Hodgkin's)
Hardell etal.(78) Survey TCE 105/335 - 7.2(1.3-42.0)
Persson et al. (55) Survey TCE 106/275 NHL 96/83 1.5(0.6-3.7) -
Siemiatycki (84) TCE(2% prevalence) 3,730/533 78 1.1 (0.6-2.3) No
¶Lymphomas, lymphosarcomas, and reticulosarcomas.
Table 13. Community-based studies.
Outcome Exposure assessment Reference Relative risk Exposed cases Comments
Bladder Solvents in town water Mallin(98) 1.7 m (1.1-2.6) 21
(includingTCE) 2.6 f(1.2-4.7) 10
Hodgkin's disease Residence in town Vartiainen etal. (87) 0.8(0.3-1.7) Hausjarvi, Finland 6
1.4(0.7-2.5) Hattula, Finland 11
Leukemia VOCs otherthan THMs Fagliano etal. (89) 1.5(1.0-2.2) f 28 Exposure response forfemales
in town water 1.0(0.7-1.5) m 25
TCE in town water Cohn et al. (90) 1.4(1.1-1.9) f 56 Exposure response forfemales
1.1 (0.8-1.4) m 63
Residence in town; Lagakos etal. (86) 2.2 (1.5-2.9) 20 Exposure response not consistent
VOCs in water MDPH (99) 2.4(0.5-10.6) 21
Residence in town Vartiainen et al. (87) 1.2(0.8-1.7) Hausjarvi, Finland 33
0.7 (0.4-1.1) Hattula, Finland 19
Residence in county Kioski et al. (93,96) 1.5(0.8-2.7) 11 Low level ofTCE in drinking water
Residence in area F Flood and Chapin (94) 0.9(0.5-1.5) 9 Childhood leukemia mortality rates
Flood et al. (95) elevated in prior study
Porter etal. (97)
Proximityto waste site Turnbull et al. (88) 592 Clustering statistically significantfor
withTCE Wailer et al. (91) some waste sites
WailerandTurnbull (92)
Liver Residence in village Vartiainen et al. (87) 0.7 (0.3-1.4) Hausjarvi, Finland 7
0.6 (0.2-1.3) Hattula, Finland 6
Multiple myeloma Residence in town Vartiainen et al. (87) 0.7 (0.3-1.3) Hausjarvi, Finland 7
0.6(0.2-1.3) Hattula, Finland 6
Non-Hodgkin's TCE in town water Cohn et al. (90) 1.4(1.1-1.7) f 87 Hint of exposure response for females
lymphoma 1.2 (0.8-1.5) m 78
Residence in town Vartiainen etal. (87) 0.6(0.3-1.1) Hausjarvi, Finland 14
1.4(1.0-2.0) Hattula, Finland 31
Various Residence in towns lsacson et al. (85) Various rate comparisons
Abbreviations: VOCs, volatile organic compounds; THMs, trihalomethanes.
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Table 14. Summary of results.
Cohort Community-
Cancer Animal Tier Tier II Tier Ill Case-control based Summary
Kidney +++ +++ +++ +++ +++solvents; +++DC *TCE/DC
Liver +++ +++ +++ +++ +++solvents; +DC - *TCE
Lung +++ 0 0 +i+ +DC *DC
Hodgkin's +++ +++ HO + +++TCE; +++solvents 0
Testes + ND
Leukemia + 0 HO - +++TCE ++
Cervical +++ 0 +++ *TCE/DC
Non-Hodgkins + HO + +++TCE; +++solvents + *TCE
lymphoma
Prostate +++ 0 HO -TCE *TCE
Multiple myeloma +++ 0 +++ *TRI
Breast 0 HO 0
Esophagus 0 HO +++ *DC
Pancreas HO HO +++ +DC *DC
Skin +++ HO HO
Brain 0 0 HO +TCE;+DC
Larynx 0 0 + ?TCE
Bladder 0 0 H+++ 0TRI; +DC + ?DC
Buccal 0 0 HO
Colon 0 0 0 +TCE; +OC ?TCE/DC
Rectum 0 0 + -TCE
Stomach 0 HO 0 -TCE
Melanoma 0 - +TCE
Abbreviations: +++, statistically significantly positive; +, positive (RR 2 1.2); 0, neutral (1.2 > RR . 0.8); -, negative (RR < 0.8); H,
results heterogeneous across studies; H+, heterogeneous but positive on average; H-, heterogeneous but negative on average; HO,
heterogeneous but neutral on average; *, evidence of risk; ?, weak suggestion of risk; ND, insufficient data.
For the liver data, Weiss (6) raises
concerns with the possible mechanism ofdis-
ease and appropriately criticizes that lack of
more specific outcome data (i.e., the separa-
tion ofthe data on cancer ofthe biliary tract
from that ofliver cancer). Nonetheless, the
data from Tier I, Tier II, and the case-con-
trol studies by and large support this associa-
tion. Interestingly, the Tier III data are
inconsistent, as are the case-control data on
dry cleaners and laundry workers, suggesting
that, in contrast to kidney, TCE is implicated
although PERC is not.
Overall, our analysis is consistent with
that of IARC (13) and Weiss (6) but sug-
gests more strongly an association ofTCE
exposure with kidney and liver cancers and
some support for Hodgkin's disease and non-
Hodgkin's lymphoma. There is also a possi-
ble association ofcervical cancer with TCE
or PERC exposure. Some data suggest associ-
ations between TCE exposure and multiple
myeloma and prostate, laryngeal, and colon
cancers. There is support for an association
between dry cleaning and laundry work
(likely PERC exposure) and kidney, pancre-
atic, cervical, esophageal, and lung cancers,
and some support for bladder and colon can-
cers. These data warrant follow-up and fur-
ther study. Overall, the results are consistent
despite the wide variety ofstudies and expo-
sures, and we strongly urge further study of
cancer risk from solvent exposures in general,
and TCE and PERC in particular.
Finally, the data on community exposure
to contaminated drinking water and
leukemia are striking, although no particular
agent has been identified adequately because
exposures are all to complex mixtures of
chemicals.
In terms of Hill's aspects of causation
(1), we find moderate support. The strength
ofassociation for kidney and liver cancer and
non-Hodgkin's lymphoma using our average
risks from Tier I are 1.7, 1.9, and 1.5,
respectively. These values are moderate but
based on a substantial number of cases.
There results are relatively consistent, with
most studies reviewed showing elevated risks.
TCE is not specific, as evidenced by the mul-
tiple cancers we study. Since we give the
greatest weight to the cohort studies, we are
emphasizing the cohort studies for which
there is implicit temporality. There are lim-
ited data on biologic gradient (or exposure
response), but these data tend to support an
association. The paucity ofsuch data limits
our ability to assess this aspect. There is plau-
sibility for several ofthe cancers mentioned,
as noted in other articles in this monograph.
There is coherence in that we do not believe
the natural history and biology of the dis-
eases conflict with TCE causing cancer.
There is experimental evidence in the animal
bioassay literature, as described in the intro-
duction of this article. Finally, we do not
know ofany appropriate analogy for TCE,
although this may reflect our lack ofimagi-
nation more than the absence ofthe analogy.
In short, although this is a subjective judg-
ment, TCE scores quite high on Hill's
aspects ofcausation.
Future Research Directions
There are two main areas in which we feel
further research is needed. First, as the next
step in the analysis ofextant data, we recom-
mend that a meta-analysis be conducted. The
goal ofthis study would be to try to isolate
factors that help explain the observed risks, as
well as to betterquantify the risk. One would
have to focus carefully on the possible hetero-
geneity among studies, carefully considering
which groups ofstudies to combine. When
combining studies in an analysis, it would be
useful to identify specific design and other
study differences that might help explain the
variation in results among studies. In addi-
tion, assessment ofinfluence and publication
bias could behelpful.
Second, further studies of workers
exposed to solvents could be helpful in eluci-
dating the observed cancer risks. Other
reviews also have found excess cancer risk
(118,119). In particular, biomarker studies,
which enable researchers to isolate exposures
to specific solvents, could be helpful in unrav-
eling some of the apparently conflicting
results reported herein. Itwould be important
to separate exposures ofTCE, PERC, 1,1,1-
trichloroethane, methylene chloride, carbon
tetrachloride, toluene, xylene, and benzene,
among other solvents. Studies should include
dry cleaner and laundry workers as a particu-
larly at risk population. Special attention
should be paid to possible confounding vari-
ables such as socioeconomic status in the
reports of cervical cancer that may help
explain the observed excesses. The most effi-
cient approach would be to use acase-control
study nested within an occupational cohort
with known TCE exposure.
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